Global Subdermal Contraceptive Implants Market, Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029
In the Subdermal Contraceptive Implants Market report, various factors such as drivers, growth opportunities, restraints, revenue sources, details on key players, etc. are included in detail.
The Subdermal Contraceptive Implants Market has been segmented on the basis of region.
Subdermal Contraceptive Implants Market Overview:
“The Subdermal Contraceptive Implants Market size is expected to be worth around US$ xx Billion by 2021 from US$ X.xx million in 2031, growing at a CAGR of X.x% during the forecast period 2021 to 2031.”
The subdermal contraceptive implant is known as a type of hormonal birth control. In order to prevent pregnancy, the implant releases the progestin hormone into the body.
By blocking the release of eggs from ovaries, progestin prevents pregnancy. Besides, preventing sperm from entering the uterus, it also thickens cervical mucus.
Subdermal contraceptive implants include delivery of steroid progestin from rods or polymer capsules placed under the skin. Subdermal contraceptive implant diffuses hormone out slowly but at a stable rate, and provides contraceptive effectiveness for around 1-5 years.
However, the protection period mainly depends upon the type of polymer and specific progestin used. It is better to insert and remove two rods than six capsules and generally, both are effective for 5 years.
There are many advantages to subdermal contraceptive implants such as long-term contraceptive action which does not require any attention from users. Subdermal contraceptive implants are highly effective at a low dose without using estrogen.
Another benefit of using subdermal contraceptive implants is that after the removal of implants, fertility is readily possible.
According to the Guttmacher Institute, almost half a million women are using contraceptive implants. Apart from advantages, there are also advantages for subdermal contraceptive implants such as breast pain, headache, nausea, weight gain, infection where the implant was inserted, and ovarian cysts.
These side effects are not as serious as they usually go away after a few months.
Subdermal Contraceptive Implants Market Dynamics:
The major factors expected to drive the growth of the subdermal contraceptive implant global market are increasing adoption of various advanced contraceptive methods, growing awareness about family planning and sexual health, and an increase in initiatives from the government.
Rising unintended pregnancies and proportional growth in the number of abortions are burdening the government by adding healthcare costs. Hence, several governments have initiated different programs to make available and improve access to various contraception methods.
Another factor driving the growth of the market is the popularity of long-acting various birth control methods.
Different Major benefits and advantages of subdermal contraceptive implants such as high effectivity, speedy return of the natural fertility once removed from the implant, cost-efficiency, and useful to women who are allergic to estragon are expected to further drive the growth of the product in the global subdermal contraceptive implants market over the forecast period.
Different governments are undertaking initiatives to make it accessible for consumers as it is cheaper and cuts costs in the healthcare sector. Numerous U.S. federal organizations have made it mandatory in health insurance coverages to increase the availability of contraceptives.
Al these factors are projected to increase demand for the product in the global subdermal contraceptive implants over the forecast period.
In addition, various cheaper subdermal contraceptive implants such as Sino-implant (II) are projected to become popular in Africa and Asia, which is expected to further drive the growth of the global subdermal contraceptive implants market over the forecast period.
Global Subdermal Contraceptive Implants Market Regional Analysis:
The North American market is projected to dominate the global subdermal contraceptive implants market regarding revenue share in terms of revenue over the forecast period.
This growth can be attributed to increasing awareness about contraceptives, high disposable income, supportive government schemes, technological advancements, rising demand for contraception, and an increased abortion rate.
Subdermal Contraceptive Implants Market Segmentation:
- Etonogestrel Implant
- Levonorgestrel Implant
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Bayer AG
- Reckitt Benckiser Group plc
- Merck Sharp & Dohme Corp.
- Church & Dwight Co., Inc.
- Teva Pharmaceutical Industries, Ltd.
- Allergan plc
- Ansell Limited (Now Humanwell)
- The Female Health Company (a division of VERU Inc.)
- Karex Industries
- Mayer Laboratories
- Kessel Medintim GmbH
- Okamato Industries, Inc.
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!